Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02602340 · ClinicalTrials.gov registry record · NA

Neurocognitive Predictors of Behavioral Therapy Response in Depression

A NA study of Depression, sponsored by Laureate Institute for Brain Research.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT02602340: Completed NA study of Depression, sponsored by Laureate Institute for Brain Research.

NCT02602340 is a NA study of Depression that has completed, run by Laureate Institute for Brain Research. The registered enrollment target is 57 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02602340, a NA study of Depression, has completed, sponsored by Laureate Institute for Brain Research.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

This project aims to identify brain and behavioral characteristics of individuals experiencing symptoms of depression that will predict the effectiveness of Behavioral Activation Therapy. Brain imaging aspects of the study will use functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). Behavioral assessments will include self-report questionnaires, computer-based and observational tasks, and interviews. Assessments will focus on how individuals process positive information (such as reward) and negative information (such as distressing images), as well as how people make decisions. These assessments will be conducted across 2-3 in-person sessions prior to beginning the treatment, and will be repeated across 2-3 in-person sessions after completing treatment. A blood draw will also be conducted pre- and post- treatment. Behavior Activation therapy will consist of 10, 90-minute weekly therapy sessions conducted in small groups.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Activation therapy

Study Locations (1)

Oklahoma

  • Laureate Institute for Brain Research - Tulsa

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2015-10-06
Est. Completion 2020-03-03
Phase NA

What the Registry Record Tells You About NCT02602340

The ClinicalTrials.gov registry entry for NCT02602340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The listed sponsor is Laureate Institute for Brain Research, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Activation therapy is the first listed.

NCT02602340 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT02602340 about?

NCT02602340 is a clinical study titled "Neurocognitive Predictors of Behavioral Therapy Response in Depression". This project aims to identify brain and behavioral characteristics of individuals experiencing symptoms of depression that will predict the effectiveness of Behavioral Activation Therapy. Brain imaging aspects of the study will use functional magnetic resonance imaging (fMRI) and electroencephalogra...

What is the current status of trial NCT02602340?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2015-10-06. Estimated completion is 2020-03-03.

What conditions does trial NCT02602340 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT02602340?

The interventions under investigation include: Behavioral Activation therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02602340?

This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02602340 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.